Numerous clinical trials are always active (ie, open and enrolling patients) in the ECOG-ACRIN Cancer Research Group, which focuses its research on adults who have or are at risk of developing cancer. The buttons below depict the general research categories being investigated in ECOG-ACRIN clinical trials. To access information within a particular category, click on the relevant button. Upon clicking, the color of the button will change from grey to red, and a table will appear on screen. The table will display the study number, study description, lead investigator(s), accrual goal, and the date the trial was activated (began enrolling patients). Please read the ECOG-ACRIN Disclaimer in its entirety before accessing this information.
To inquire about a particular trial, send us an email using our contact form. Alternatively, send an email to the study chair; click on their hyperlinked name and a new email window will open. To view educational materials, click on the links provided in the Educational Materials column.
Gastrointestinal Cancer Trials Currently Recruiting Participants
STUDY DESCRIPTION ECOG-ACRIN STUDY CHAIR
EA2142 Randomized Phase II Study of Cisplatin and Etoposide versus Temozolomide and Capecitabine in Patients with Advanced G3 Non-Small Cell Gastroenteropancreatic Neuroendocrine Carcinomas Jennifer R. Eads, MD, Chair
George Fisher, MD, PhD, Co-Chair
126 11/06/2015 EA2142 Resources
EA2161 A Phase II Study of the mTOR Inhibitor TAK-228 (formerly MLN0128) in Patients with Advanced Pancreatic Neuroendocrine Tumors That are Resistant to Rapalogs Lakshmi N. Rajdev, MD, MS,
Steven K. Libutti, MD, Co-Chair
Al B. Benson, III, MD, PhD, Co-Chair
(Paul J. Catalano, ScD)
40 02/01/2017 EA2161 Resources
7151 Incidence and Significance of Extracolonic Findings on CT Colonography:
Retrospective Analysis of National CT Colonography Trial Data
***Patients are being recruited by invitation only.***
Note: This trial is a substudy of A6664, the national CT colonography screening trial of healthy participants. A7151 is funded by the ACRIN Fund for Imaging Innovation.
Hanna M. Zafar, MD, MHS, Chair
William C. Black, MD, Co-Chair
(Jeremy Gorelick, PhD)
520 09/16/2011 7151 Resources